<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05028283</url>
  </required_header>
  <id_info>
    <org_study_id>UDMS-Derma-01-2021</org_study_id>
    <nct_id>NCT05028283</nct_id>
  </id_info>
  <brief_title>Treatment of Atrophic Post Acne Scars by Fat Grafting</brief_title>
  <official_title>Autologous Fat Cells Transfer for the Treatment of Atrophic Post Acne Scars: Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This single-center, clinical trial consists of a one autologous fat grafting treatment&#xD;
      followed by1-week , 1month , 3-month and 6-month post-treatment visits in order to assess the&#xD;
      efficacy and complications of fat grafting when used for facial atrophic acne scars on&#xD;
      cheeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This investigation, pilot study will evaluate the safety and efficacy of autologous fat&#xD;
      grafting for the treatment of atrophic acne scarring on cheeks. Overall assessment of&#xD;
      clinical outcome and safety will be based clinic visits and evaluation of pre- and post-&#xD;
      procedural on the Goodman-Barron scale.&#xD;
&#xD;
      The subject's assessment of satisfaction will be characterized using a non-parametric&#xD;
      assessment scale at the end of the follow-up period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 19, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">August 19, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>• Change in atrophic acne scars assessment</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <description>Acne scars will be used to evaluate efficacy of treatment using the Goodman- Barron scale [which is an acne scars severity scale divided into 4 grades&#xD;
First grade consists of hyper-or hypopigmented flat marks&#xD;
Second grade consists of mild atrophy or hypertrophy that may not be obvious at social distances of 50 cm or greater and may be covered adequately by makeup&#xD;
Third grade consists of moderate atrophic or hypertrophic scarring that is obvious at social distances of 50 cm or greater and is not covered easily by makeup or the normal shadow&#xD;
Fourth grade severe atrophic or hypertrophic scarring that is obvious at social distances of 50 cm or greater and is not covered easily by makeup or the normal shadow].&#xD;
The grade of acne scars from final visit will be compared to their baseline grade visually evaluated by the study team.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in patient satisfaction</measure>
    <time_frame>3 Months, and 6 Months</time_frame>
    <description>The modified global aesthetic improvement scale for patient evaluation module which consists of 5 degrees&#xD;
Exceptionally improved [The ideal result has been achieve]&#xD;
much improved[The result is much improved but suboptimal]&#xD;
Improved[The result is improved but an additional procedure is recommended ]&#xD;
no difference[The result is the same when compared with the preoperative state]&#xD;
Worse[The result is worse when compared with the preoperative state] This module will be administered 3monts and 6 months postoperatively to analyze satisfaction and aesthetic perception of the result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Infection existence</measure>
    <time_frame>1 week, 1 month, 3 months and 6 Months</time_frame>
    <description>Patients will be examined after procedure to check existence of infection and will be monitored until it will heal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bruising Status</measure>
    <time_frame>Baseline ,1 week 1 month,3 months and 6 Months</time_frame>
    <description>Patients will be examined after procedure to check bruising status and will be monitored until it will disappear</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Erythema Presence</measure>
    <time_frame>Baseline ,1 week ,1 month,3 months and 6 Months</time_frame>
    <description>Patients will be examined after procedure to check erythema presence and will be monitored until it will disappear</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Swelling Status</measure>
    <time_frame>Baseline ,1 week 1month,3 months and 6 Months</time_frame>
    <description>Patients will be examined after procedure to check swelling status and will be monitored until it will disappear</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Irregularity Presence</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <description>Patients will be examined after procedure to check irregularity presence at the end of the study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">69</enrollment>
  <condition>Atrophic Acne Scars</condition>
  <arm_group>
    <arm_group_label>participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with atrophic acne scars on the cheeks who will reviewing the dermatological clinics at the Dermatology and Venereology Hospital at least 69 patients they will be undergo fat grafting for one session and will be follow up for 6 months after the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fat Grafting</intervention_name>
    <description>This single-center, clinical trial will assess the efficacy and tolerability of the autologous fat grafting when used on men and women with atrophic acne scars on the cheeks</description>
    <arm_group_label>participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with atrophic post acne scars on the cheeks, between 20 - 40 years old&#xD;
&#xD;
          -  Not to apply other treatments a month before the procedure&#xD;
&#xD;
          -  Informed consent to enter the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  First grade of Goodman - Barron scale.&#xD;
&#xD;
          -  A systemic or associated skin disease that may affect the results of the study&#xD;
&#xD;
          -  patients with chronic consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) or&#xD;
             other non-aggregating agents.&#xD;
&#xD;
          -  Patients with acne in the acute stage&#xD;
&#xD;
          -  Pregnancy and breastfeeding&#xD;
&#xD;
          -  Tendency to form keloids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rahaf Alkhouli, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Department, University of Damascus Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>RAHAF ALKHOULI, MSc</last_name>
    <phone>+963 998915224</phone>
    <email>Rahafkhouli@Hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manal Mouhamad, MSc PhD</last_name>
    <phone>+963993656163</phone>
    <email>Manalqussai2@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dermatology and Venereology Hospital</name>
      <address>
        <city>Damascus</city>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manal Mouhamad, MSc, PhD</last_name>
      <phone>+963993656163</phone>
      <email>Manalqussai2@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <reference>
    <citation>Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012 Jan 28;379(9813):361-72. doi: 10.1016/S0140-6736(11)60321-8. Epub 2011 Aug 29. Review. Erratum in: Lancet. 2012 Jan 28;379(9813):314.</citation>
    <PMID>21880356</PMID>
  </reference>
  <reference>
    <citation>Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol. 1999 Aug;141(2):297-300.</citation>
    <PMID>10468803</PMID>
  </reference>
  <reference>
    <citation>Boen M, Jacob C. A Review and Update of Treatment Options Using the Acne Scar Classification System. Dermatol Surg. 2019 Mar;45(3):411-422. doi: 10.1097/DSS.0000000000001765. Review.</citation>
    <PMID>30856634</PMID>
  </reference>
  <reference>
    <citation>Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr; Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50. doi: 10.1016/j.jaad.2009.01.019. Review.</citation>
    <PMID>19376456</PMID>
  </reference>
  <reference>
    <citation>Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001 Apr;7(2):211-28.</citation>
    <PMID>11304456</PMID>
  </reference>
  <reference>
    <citation>Coleman SR. Facial augmentation with structural fat grafting. Clin Plast Surg. 2006 Oct;33(4):567-77.</citation>
    <PMID>17085224</PMID>
  </reference>
  <reference>
    <citation>Zeltzer AA, Tonnard PL, Verpaele AM. Sharp-needle intradermal fat grafting (SNIF). Aesthet Surg J. 2012 Jul;32(5):554-61. doi: 10.1177/1090820X12445082.</citation>
    <PMID>22745443</PMID>
  </reference>
  <reference>
    <citation>Lindenblatt N, van Hulle A, Verpaele AM, Tonnard PL. The Role of Microfat Grafting in Facial Contouring. Aesthet Surg J. 2015 Sep;35(7):763-71. doi: 10.1093/asj/sjv083. Epub 2015 Jun 2.</citation>
    <PMID>26038369</PMID>
  </reference>
  <reference>
    <citation>Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013 Oct;132(4):1017-1026. doi: 10.1097/PRS.0b013e31829fe1b0.</citation>
    <PMID>23783059</PMID>
  </reference>
  <reference>
    <citation>Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006 Dec;32(12):1458-66.</citation>
    <PMID>17199653</PMID>
  </reference>
  <reference>
    <citation>Sezgin B, Özmen S. Fat grafting to the face with adjunctive microneedling: a simple technique with high patient satisfaction. Turk J Med Sci. 2018 Jun 14;48(3):592-601. doi: 10.3906/sag-1711-42.</citation>
    <PMID>29914257</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acne- atrophic scars - autologous fat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

